BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9740134)

  • 21. College of American Pathologists Conference XXVIII on alternate site testing: keynote address. Global view of how alternate site testing fits in with medical care.
    O'Leary D
    Arch Pathol Lab Med; 1995 Oct; 119(10):877-80. PubMed ID: 7487381
    [No Abstract]   [Full Text] [Related]  

  • 22. College of American Pathologists Foundation Conference VIII on patient-centered pathology practice--outcomes and accountability. Overview, glossary, and bibliography.
    Vance RP; Elevitch FR
    Arch Pathol Lab Med; 1997 Nov; 121(11):1151-62. PubMed ID: 9372741
    [No Abstract]   [Full Text] [Related]  

  • 23. Patient self-management of oral anticoagulation.
    Fancher TL; White RH
    Curr Hematol Rep; 2004 Sep; 3(5):368-74. PubMed ID: 15341705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice guidelines for autopsy pathology. Autopsy performance. Autopsy Committee of the College of American Pathologists.
    Hutchins GM
    Arch Pathol Lab Med; 1994 Jan; 118(1):19-25. PubMed ID: 8285830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded coverage for warfarin patients in the USA monitoring clotting time at home.
    Cardiovasc J Afr; 2011; 22(5):280. PubMed ID: 21983956
    [No Abstract]   [Full Text] [Related]  

  • 27. [From Quick's percentage to the INR (International Normalized Ratio)--a real advance in the control of oral anticoagulation].
    Beck EA
    Schweiz Med Wochenschr; 1985 Oct; 115(40):1378-80. PubMed ID: 4071012
    [No Abstract]   [Full Text] [Related]  

  • 28. Clearing the way: treating venous thromboembolism and deep vein thrombosis.
    Lambing A
    Adv Nurse Pract; 2005 Jun; 13(6):24-30; quiz 31. PubMed ID: 15984353
    [No Abstract]   [Full Text] [Related]  

  • 29. The truth about activated clotting time measurements.
    Bittl JA
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):338-9. PubMed ID: 15864807
    [No Abstract]   [Full Text] [Related]  

  • 30. College of American Pathologists Conference XXVII on the Impact of Managed Care on the Practice of Pathology: keynote address.
    Cahill N
    Arch Pathol Lab Med; 1995 Jul; 119(7):602-4. PubMed ID: 7625900
    [No Abstract]   [Full Text] [Related]  

  • 31. New anticoagulants.
    Agnelli G; Becattini C
    Semin Thromb Hemost; 2006 Nov; 32(8):793-802. PubMed ID: 17171592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
    Young L; Ockelford P; Harper P
    Intern Med J; 2004 Nov; 34(11):639-41. PubMed ID: 15546458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anticoagulant therapy of thromboembolism. I].
    Schöndorf T
    Med Welt; 1973 May; 24(20):803-5. PubMed ID: 4753896
    [No Abstract]   [Full Text] [Related]  

  • 34. [The problem of the control of anticoagulant therapy].
    Chini V; Guidi L; Panesi M; Villani C
    Boll Soc Ital Cardiol; 1966; 11(1):175-9. PubMed ID: 5938070
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of the laboratory accreditation programme of the College of American Pathologists.
    Abu-Amero KK
    East Mediterr Health J; 2002; 8(4-5):654-63. PubMed ID: 15603049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. College of American pathologists experience with the linearity surveys, 1987-1991.
    Floering DA
    Arch Pathol Lab Med; 1992 Jul; 116(7):739-45. PubMed ID: 1497447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternative extrinsic coagulation pathway and oral anticoagulant treatment.
    Cassetti M; Palazzesi G; Trimarchi A; Barzetta R
    Quad Sclavo Diagn; 1984 Mar; 20(1):105-9. PubMed ID: 6494410
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent developments in the use of oral anticoagulants.
    Lassen MR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1769-81. PubMed ID: 19548861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticoagulant therapy. II. (Possibilities and limits)].
    Fischer M
    Med Welt; 1970 Apr; 14():620-6. PubMed ID: 5445111
    [No Abstract]   [Full Text] [Related]  

  • 40. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A laboratory perspective.
    Kottke-Marchant K
    Lab Hematol; 2004; 10(3):173-5. PubMed ID: 15529440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.